Developments in liver transplantation for hepatocellular carcinoma

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 510-521

  Melloul, Emmanuel ^a   Lesurtel, Mickael ^a   Carr, Brian I ^b   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; INTERLEUKIN 2; LICARTIN; MAMMALIAN TARGET OF RAPAMYCIN; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SORAFENIB; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONFERENCE PAPER; DISEASE FREE SURVIVAL; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE PROLIFERATION; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEOMICS; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSCRIPTOMICS; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOSUPPRESSION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS;

EID: 84864430551     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.008     Document Type: Conference Paper

References (112)

1. S. Iwatsuki, R.D. Gordon, B.W. Shaw Jr, T.E. Starzl Role of liver transplantation in cancer therapy Ann Surg 202 1985 401 407
2. V. Mazzaferro, E. Regalia, R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
3. ELTR - European Liver Transplant Registry Cited January 2011 www.eltr.org
4. OPTN - Organ Procurement and Transplantation Network Cited January 2011 www.ustransplant.org/annual-reports
5. V. Mazzaferro, S. Bhoori, C. Sposito et al. Milan criteria in liver transplantation for HCC: an evidence-based analysis on 15 years of experience Liver Transpl 17 Suppl 2 2011 S44 S57
6. F.Y. Yao, L. Ferrell, N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
7. F.Y. Yao, L. Xiao, N.M. Bass, R. Kerlan, N.L. Ascher, J.P. Roberts Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587 2596
8. J.P. Duffy, A. Vardanian, E. Benjamin Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 509
9. J.W. Chen, L. Kow, D.J. Verran Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF criteria An analysis of liver transplantation in HCC in Australia and New Zealand HPB (Oxford) 11 2009 81 89
10. T. Decaens, F. Roudot-Thoraval, S. Hadni-Bresson Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time Liver Transpl 12 2006 1761 1769
11. V. Mazzaferro, J.M. Llovet, R. Miceli Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
12. F. D'Amico, M. Schwartz, A. Vitale Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria Liver Transpl 15 2009 1278 1287
13. C. Toso, S. Asthana, D.L. Bigam, A.M. Shapiro, N.M. Kneteman Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 2009 832 838
14. D. DuBay, C. Sandroussi, L. Sandhu Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion Ann Surg 253 2011 166 172
15. J. Bruix, M. Sherman, J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
16. J. Bruix, M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
17. B. Mullhaupt, F. Durand, T. Roskams, P. Dutkowski, M. Heim Is tumor biopsy necessary? Liver Transpl 17 Suppl 2 2011 S14 S25
18. P.H. Hayashi, J.F. Trotter, L. Forman Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD Liver Transpl 10 2004 42 48
19. R.H. Wiesner, R.B. Freeman, D.C. Mulligan Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy Gastroenterology 127 5 Suppl 1 2004 S261 S267
20. P. Compagnon, S. Grandadam, R. Lorho Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy Transplantation 86 2008 1068 1076
21. E. Caturelli, M. Bisceglia, S. Fusilli, M.M. Squillante, M. Castelvetere, D.A. Siena Cytological vs microhistological diagnosis of hepatocellular carcinoma: comparative accuracies in the same fine-needle biopsy specimen Dig Dis Sci 41 1996 2326 2331
22. E. Caturelli, L. Solmi, M. Anti Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study Gut 53 2004 1356 1362
23. F. Durand, J. Belghiti, V. Paradis Liver transplantation for hepatocellular carcinoma: role of biopsy Liver Transpl 13 11 Suppl 2 2007 S17 S23
24. J.M. Llovet, R. Vilana, C. Bru Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma Hepatology 33 2001 1124 1129
25. D.L. Diamond, A.L. Krasnoselsky, K.E. Burnum Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus mediated liver disease post-transplantation Hepatology 2012 Feb 13 10.1002/hep.25649 Hepatology. 2012 Feb 13
26. R. Gehrau, D. Maluf, K. Archer Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients Mol Med 17 2011 824 833
27. V.R. Mas, D.G. Maluf, K.J. Archer, K. Yanek, K. Bornstein, R.A. Fisher Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation Transplantation 87 2009 143 152
28. K. Breuhahn, G. Gores, P. Schirmacher Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches Hepatology 53 2011 2112 2121
29. J.S. Lee, S.S. Thorgeirsson Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets Gastroenterology 127 5 Suppl 1 2004 S51 S55
30. Z. Liu, Y. Ma, J. Yang, H. Qin Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies OMICS 15 2011 61 71
31. B. Minguez, A. Lachenmayer Diagnostic and prognostic molecular markers in hepatocellular carcinoma Dis Markers 31 2011 181 190
32. A. Suriawinata, S.N. Thung Molecular signature of early hepatocellular carcinoma Oncology 78 Suppl 1 2010 36 39
33. S. Toffanin, Y. Hoshida, A. Lachenmayer et al. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a Gastroenterology 140 2011 1618 1628
34. R. Gehrau, V. Mas, K.J. Archer, D. Maluf Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation Expert Rev Gastroenterol Hepatol 5 2011 539 552
35. J.M. Llovet, V. Paradis, M. Kudo, J. Zucman-Rossi Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma Liver Transpl 17 Suppl 2 2011 S67 S71
36. C. Schmidt, J.W. Marsh Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment Curr Opin Organ Transplant 15 2010 277 282
37. A. Zarrinpar, F. Kaldas, R.W. Busuttil Liver transplantation for hepatocellular carcinoma: an update Hepatobiliary Pancreat Dis Int 10 2011 234 242
38. H. Imamura, Y. Matsuyama, E. Tanaka Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 2003 200 207
39. S. Iwatsuki, T.E. Starzl, D.G. Sheahan Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 228
40. B. Ringe, R. Pichlmayr, C. Wittekind, G. Tusch Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients World J Surg 15 1991 270 285
41. W. Liu, F. He, Y. Jiang Network-based discovery of gene signature for vascular invasion prediction in HCC J Hepatol 56 2012 1423
42. B. Minguez, Y. Hoshida, A. Villanueva Gene-expression signature of vascular invasion in hepatocellular carcinoma J Hepatol 55 2011 1325 1331
43. T.L. Pan, P.W. Wang, C.C. Huang, C.T. Yeh, T.H. Hu, J.S. Yu Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells J Proteomics 2012 Feb 22
44. Y. Hoshida, A. Villanueva, M. Kobayashi Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
45. M. Okamoto, T. Utsunomiya, S. Wakiyama Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients Ann Surg Oncol 13 2006 947 954
46. P. Pancoska, B.I. Carr, R.A. Branch Network-based analysis of survival for unresectable hepatocellular carcinoma Semin Oncol 37 2010 170 181
47. M. Tsuchiya, J.S. Parker, H. Kono, M. Matsuda, H. Fujii, I. Rusyn Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma Mol Cancer 9 2010 74
48. A. Russo, S. Rizzo, G. Bronte The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway Oncology 77 Suppl 1 2009 57 68
49. G.K. Abou-Alfa, L. Schwartz, S. Ricci Phase II study of sorafenib in patients with advanced hepatocellular carcinoma J Clin Oncol 24 2006 4293 4300
50. A.X. Zhu Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)? BMC Med 7 2009 42
51. A.O. Kaseb, E. Garrett-Mayer, J.S. Morris Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial Oncology 82 2012 67 74
52. A.S. Gouw, C. Balabaud, H. Kusano, S. Todo, T. Ichida, M. Kojiro Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17 Suppl 2 2011 S72 S80
53. S. Jonas, W.O. Bechstein, T. Steinmuller Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
54. A. Plessier, L. Codes, Y. Consigny Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma Liver Transpl 10 2 Suppl 1 2004 S86 S90
55. S. Bhattacharjya, T. Bhattacharjya, A. Quaglia Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators Dig Surg 21 2004 152 159
56. K.W. Lee, J.W. Park, J.W. Joh Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation? Transplant Proc 36 2004 2289 2290
57. 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients Am J Transplant 9 2009 592 600
58. C. Toso, G. Mentha, P. Majno Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence Am J Transplant 11 2011 2031 2035
59. Z.F. Yang, P. Ngai, D.W. Ho Identification of local and circulating cancer stem cells in human liver cancer Hepatology 47 2008 919 928
60. P.E. Majno, R. Lencioni, F. Mornex, N. Girard, R.T. Poon, D. Cherqui Is treatment of HCC on the waiting list necessary? Liver Transpl 17 Suppl 2 2011 S98 S108
61. M. Lesurtel, B. Mullhaupt, B.C. Pestalozzi, T. Pfammatter, P.A. Clavien Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2006 2644 2650
62. P.M. Porrett, H. Peterman, M. Rosen Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era Liver Transpl 12 2006 665 673
63. M. Pompili, V.G. Mirante, G. Rondinara Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence Liver Transpl 11 2005 1117 1126
64. A. Riaz, L. Kulik, R.J. Lewandowski Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres Hepatology 49 2009 1185 1193
65. V. Mazzaferro, C. Battiston, S. Perrone Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study Ann Surg 240 2004 900 909
66. J.M. Llovet, X. Mas, J.J. Aponte Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation Gut 50 2002 123 128
67. D. Cherqui, A. Laurent, N. Mocellin Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation Ann Surg 250 2009 738 746
68. D. Fuks, S. Dokmak, V. Paradis, M. Diouf, F. Durand, J. Belghiti Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis Hepatology 55 2012 132 140
69. M.L. Barr, J. Belghiti, F.G. Villamil A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines Transplantation 81 2006 1373 1385
70. J.F. Trotter, R. Adam, C.M. Lo, J. Kenison Documented deaths of hepatic lobe donors for living donor liver transplantation Liver Transpl 12 2006 1485 1488
71. C.M. Miller Ethical dimensions of living donation: experience with living liver donation Transplant Rev (Orlando) 22 2008 206 209
72. D.C. Cronin 2nd, J.M. Millis Living donor liver transplantation: The ethics and the practice Hepatology 47 2008 11 13
73. D.C. Cronin 2nd, J.M. Millis, M. Siegler Transplantation of liver grafts from living donors into adults - too much, too soon N Engl J Med 344 2001 1633 1637
74. E.A. Pomfret, J.P. Lodge, F.G. Villamil, M. Siegler Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations Liver Transpl 17 Suppl 2 2011 S128 S132
75. M. Siegler, M.C. Simmerling, J.H. Siegler, D.C. Cronin 2nd Recipient deaths during donor surgery: a new ethical problem in living donor liver transplantation (LDLT) Liver Transpl 12 2006 358 360
76. S. Di Sandro, A.O. Slim, A. Giacomoni Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation Transplant Proc 41 2009 1283 1285
77. R.A. Fisher, L.M. Kulik, C.E. Freise Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation Am J Transplant 7 2007 1601 1608
78. S. Hwang, S.G. Lee, J.W. Joh, K.S. Suh, D.G. Kim Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations Liver Transpl 11 2005 1265 1272
79. L. Kulik, M. Abecassis Living donor liver transplantation for hepatocellular carcinoma Gastroenterology 127 5 Suppl 1 2004 S277 S282
80. C.M. Lo, S.T. Fan, C.L. Liu, S.C. Chan, I.O. Ng, J. Wong Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma Br J Surg 94 2007 78 86
81. K. Vakili, J.J. Pomposelli, Y.L. Cheah Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival Liver Transpl 15 2009 1861 1866
82. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, A. Perrier Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2011 e11 e22
83. D. Grant, R.A. Fisher, M. Abecassis, G. McCaughan, L. Wright, S.T. Fan Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation? Liver Transpl 17 Suppl 2 2011 S133 S138
84. J.J. Fung, A. Jain, E.J. Kwak, S. Kusne, I. Dvorchik, B. Eghtesad De novo malignancies after liver transplantation: a major cause of late death Liver Transpl 7 11 Suppl 1 2001 S109 S118
85. A.A. Schnitzbauer, H.J. Schlitt, E.K. Geissler Influence of immunosuppressive drugs on the recurrence of hepatocellular carcinoma after liver transplantation: a gap between basic science and clinical evidence Transplantation 91 2011 1173 1176
86. M. Guba, C. Graeb, K.W. Jauch, E.K. Geissler Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 2004 1777 1782
87. M. Hojo, T. Morimoto, M. Maluccio Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature 397 1999 530 534
88. G. Schumacher, M. Oidtmann, S. Rosewicz Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth Transplant Proc 34 2002 1392 1393
89. D. Semela, A.C. Piguet, M. Kolev Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma J Hepatol 46 2007 840 848
90. C. Soll, P.A. Clavien Inhibition of mammalian target of rapamycin: two goals with one shot? J Hepatol 54 2011 182 183
91. S. Chinnakotla, G.L. Davis, S. Vasani Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation Liver Transpl 15 2009 1834 1842
92. C. Toso, G.A. Meeberg, D.L. Bigam De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects Transplantation 83 2007 1162 1168
93. C. Toso, S. Merani, D.L. Bigam, A.M. Shapiro, N.M. Kneteman Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma Hepatology 51 2010 1237 1243
94. M. Vivarelli, A. Dazzi, M. Zanello Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma Transplantation 89 2010 227 231
95. J. Zhou, Z. Wang, Z.Q. Wu Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria Transplant Proc 40 2008 3548 3553
96. M.A. Zimmerman, R.M. Ghobrial, M.J. Tong Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators Arch Surg 143 2008 182 188
97. W. Liang, D. Wang, X. Ling Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis Liver Transpl 18 2012 62 69
98. A.A. Schnitzbauer, C. Zuelke, C. Graeb A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma BMC Cancer 10 2010 190
99. G.H. Chen, M.Q. Lu, C.J. Cai, Y. Yang, X.S. He, X.F. Zhu [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation] Zhonghua Wai Ke Za Zhi 42 2004 1040 1043
100. D. Cherqui, P. Piedbois, J.Y. Pierga Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma A pilot study Cancer 73 1994 2721 2726
101. C.B. Hsieh, S.J. Chou, M.L. Shih Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma Eur J Surg Oncol 34 2008 906 910
102. K.M. Olthoff, M.H. Rosove, C.R. Shackleton Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma Ann Surg 221 1995 734 741
103. S. Roayaie, J.S. Frischer, S.H. Emre Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539
104. M.J. Stone, G.B. Klintmalm, D. Polter Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients Gastroenterology 104 1993 196 202
105. J. Sun, B.H. Hou, Z.X. Jian, Y.L. Ou, J.R. Ou [Value of perioperative adjuvant therapy in liver transplantation for advanced hepatocellular carcinoma] Nan Fang Yi Ke Da Xue Xue Bao 27 2007 471 473
106. Z.H. Zhang, L.W. Ma, S.B. Song [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma] Zhonghua Zhong Liu Za Zhi 27 2005 45 47
107. N. Li, J. Zhou, D. Weng Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma Clin Cancer Res 13 2007 5847 5854
108. H. Pokorny, M. Gnant, S. Rasoul-Rockenschaub Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? Am J Transplant 5 2005 788 794
109. G. Soderdahl, L. Backman, H. Isoniemi A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma Transpl Int 19 2006 288 294
110. Q. Zhang, H. Chen, Q. Li Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study Invest New Drugs 29 2011 1360 1369
111. J. Xu, Z.Y. Shen, X.G. Chen A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation Hepatology 45 2007 269 276
112. J.M. Llovet, S. Ricci, V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390